TYSON CORBIN: Open Payments
NPI 1336407378 · SPRINGFIELD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 39 payments from 11 companies in 2025. Trend: 2023 $444 · 2024 $1,096 · 2025 $858
Food & beverage: $774Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $382 |
| Madrigal Pharmaceuticals | 4 | $208 |
| Janssen Biotech, Inc. | 2 | $101 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $19 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: REZDIFFRA, SKYRIZI, TREMFYA, RINVOQ, LINZESS, ZENPEP, CREON, DUPIXENT.
Industry payments across IL — which companies pay providers there.
